What is the AVBP stock price prediction for next 2 weeks?

According to our price prediction algorithm,ArriVent BioPharma, Inc. Common Stock (AVBP) price will be around $21.22 in the next 2 weeks. This means it will decrease by -4.693171608265959 from the last closing price. This prediction may vary from other time period filters for AVBP stock.

What can be the highest Possible price of AVBP stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, AVBP can achieve the highest price of $22.58 which is 1.416369181792127 higher than last closing price. This prediction may vary from other time period filters for AVBP stock.

What can be the lowest Possible price of AVBP stock in next 2 weeks?

As per the forecast and algorithmic analysis, AVBP stock price can be as low as $19.72 which is -11.392472761544099 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for AVBP stock.

Will AVBP stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that AVBP stock will lose-4.693171608265959 in the next 2 weeks. This prediction may vary from other time period filters for AVBP stock.

What is AVBP stock last closing price?

Last closing price of AVBP stock was $22.26.

What is AVBP stock price prediction?

AVBP stock price prediction means predicting the future closing prices of AVBP stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of AVBP stock in a certain time period.

How we predict AVBP stock future prices?

If you are searching for AVBP stock forecast, analysis or price prediction, then you might be wondering what ArriVent BioPharma, Inc. Common Stock (AVBP) will do in the future. Our AVBP price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This AVBP price prediction will likely answer most of your questions.

How frequent we update AVBP stock predictions?

We are updating the forecasts for the AVBP stock on daily basis.

Is using ML forecasting for AVBP stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for AVBP stock same for all the time periods?

No, the prediction for AVBP stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

ArriVent BioPharma, Inc. Common Stock Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$22.2613.34%Since 2 Weeks

Predicted Price$21.22-4.69%For 2 Weeks

Upper Predicted Price$22.581.42%For 2 Weeks

Lower Predicted Price$19.72-11.39%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of AVBP will decline by -4.69% over the next 2 Weeks and hit $21.22 by Tuesday, February 3, 2026. In that time frame, AVBP's share price is expected to range between $19.72 and $22.58.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Feb 3, 2026	19.72	21.22	22.58
Feb 2, 2026	20.08	21.49	22.96
Jan 30, 2026	20.50	21.94	23.37
Jan 29, 2026	20.97	22.47	24.01
Jan 28, 2026	20.30	21.79	23.21
Jan 27, 2026	20.23	21.74	23.26
Jan 26, 2026	20.51	22.02	23.49
Jan 23, 2026	21.01	22.46	23.95
Jan 22, 2026	21.60	22.99	24.49
Jan 21, 2026	20.85	22.31	23.74

AVBP shares rose +2.65% in Wednesday, January 21, 2026's trading session, rising from a previous close of $22.26 to move at $22.85. The stock demonstrated notable intraday movement (see AVBP's key stats for a full breakdown), fluctuating between $22.01 and $23.10, a +4.96% trading range. While recent weeks have seen some volatility, AVBP has managed to secure a +20.71% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 473.35K shares changing hands, 74.12K more than the previous session. This amounted to $10.82M in total market activity.

Will AVBP Continue Its Downward Trend?

According to analyst ratings and projections for AVBP, ArriVent BioPharma, Inc. Common Stock shares are anticipated to decrease by -1.22%, potentially reaching $22.58 per share by February 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for AVBP. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the AVBP stock forecast, now is not the best time to buy AVBP stock because its current trading price is +7.71% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on AVBP covering social and institutional perspectives.

AVBP Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into AVBP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 56.01% to 62.16%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 53.30%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 51.56%, maintains a neutral outlook for the long term. Insights into AVBP's shareholder base show how institutional investors are positioning themselves during these momentum shifts

ArriVent BioPharma Common Stock Short-Term Forecasts

AVBP Forecast For Next 5 Days

Our algorithm anticipates ArriVent BioPharma Common Stock (AVBP) stock could hit $21.96 by Jan 28, 2026. This represents a -3.88% rise from today's price, following a +8.90% change over the past five days.

AVBP Forecast For Next 30 Days

Based on analysis of market trends, the outlook for ArriVent BioPharma, Inc. Common Stock (AVBP) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $22.84, which would mean a -0.04% decrease from the current price of $22.85. Projections for this period range from a high of $27.29 to a low of $18.18.

AVBP Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for ArriVent BioPharma Common Stock's price over the next three months point to a drop. AVBP stock is expected to peak at $23.57 on Apr 20, 2026 after potentially dipping to $17.46 on Feb 12, 2026. On average, AVBP is likely to trade around $20.20 in the coming 90 days.

ArriVent BioPharma Common Stock Stock Forecast 2025

Based on our predictive models, ArriVent BioPharma Common Stock (AVBP) is expected to trade between $17.32 and $26.94 throughout 2026. This would result in an average price of $20.34, potentially offering investors a -10.98% return from current levels.

ArriVent BioPharma, Inc. Common Stock Monthly Forecast 2026–2027

January 2026

According to our latest forecast models, ArriVent BioPharma, Inc. Common Stock (AVBP) is positioned to show a strong performance in January 2026. The price is predicted to move between $18.85 and $22.37, settling at an average of $20.60. This could translate to a -9.85% loss.

February 2026

Based on current market signals, ArriVent BioPharma, Inc. Common Stock is projected to trend february 2026. We forecast a trading range from $17.46 to $22.18, with a likely average price of $19.86. Investors could expect a potential return of -13.09%.

March 2026

Our predictive algorithms indicate ArriVent BioPharma, Inc. Common Stock stock may see a shift in March 2026. The expected range spans $17.97–$22.06, with an average target of $19.99. This represents a cautious outlook and a possible loss of -12.52%.

April 2026

Analyzing established trends, ArriVent BioPharma, Inc. Common Stock looks set to move in April 2026. Projections place the stock between $18.52 and $24.03, averaging around $21.11. This suggests a -7.61% loss from current levels.

May 2026

Market indicators suggest ArriVent BioPharma, Inc. Common Stock could experience notable changes during May 2026. Prices could fluctuate within $18.35 to $23.19, with a midpoint forecast of $20.56. The stock might deliver a -10.02% loss.

June 2026

Forecasting for June 2026, models estimate that ArriVent BioPharma, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $18.22 and $22.72, averaging $20.33. This signals a cautious trajectory with potential returns around -11.03%.

July 2026

According to our latest forecast models, ArriVent BioPharma, Inc. Common Stock (AVBP) is positioned to show a strong performance in July 2026. The price is predicted to move between $17.32 and $22.49, settling at an average of $19.85. This could translate to a -13.13% loss.

August 2026

Based on current market signals, ArriVent BioPharma, Inc. Common Stock is projected to trend august 2026. We forecast a trading range from $17.80 to $21.96, with a likely average price of $19.92. Investors could expect a potential return of -12.82%.

September 2026

Our predictive algorithms indicate ArriVent BioPharma, Inc. Common Stock stock may see a shift in September 2026. The expected range spans $18.55–$23.61, with an average target of $21.16. This represents a cautious outlook and a possible loss of -7.40%.

October 2026

Analyzing established trends, ArriVent BioPharma, Inc. Common Stock looks set to move in October 2026. Projections place the stock between $18.28 and $25.38, averaging around $20.48. This suggests a -10.37% loss from current levels.

November 2026

Market indicators suggest ArriVent BioPharma, Inc. Common Stock could experience notable changes during November 2026. Prices could fluctuate within $18.01 to $26.94, with a midpoint forecast of $20.60. The stock might deliver a -9.85% loss.

December 2026

Forecasting for December 2026, models estimate that ArriVent BioPharma, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $17.34 and $22.04, averaging $19.74. This signals a cautious trajectory with potential returns around -13.61%.

January 2027

According to our latest forecast models, ArriVent BioPharma, Inc. Common Stock (AVBP) is positioned to show a strong performance in January 2027. The price is predicted to move between $17.88 and $21.79, settling at an average of $19.66. This could translate to a -13.96% loss.

AVBP's history of dividends and stock splits also plays a role in long-term investor confidence.